KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program

Title
KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program
Authors
Keywords
KIAA1199, Sorafenib tolerance, Metastasis, EMT, Hepatocellular carcinoma
Journal
CANCER LETTERS
Volume 454, Issue -, Pages 78-89
Publisher
Elsevier BV
Online
2019-04-11
DOI
10.1016/j.canlet.2019.03.049

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now